[ 38 ] Angiotensin-converting enzyme inhibitors (ACEIs)/Angiotensin receptor blockers (ARBs)Concerning ACEIs, perindopril was the first drug that showed a trend to reduce the primary endpoint of HF hospitalization or all-cause death in the PEP-CHF (Perindopril for Elderly People With Chronic Heart Failure) trial (HR = 0.69, 95% CI: 0.47−1.01; P = 0.055).
1
—
—